Where Biotech Meets Partnerships
Ideas Brewed. Futures Composed
The BIO-Europe 2025 agenda is infused with the coffeeshop culture and musical legacy of Vienna. Blending cutting-edge science and partnerships, the program is crafted to inform, inspire and ignite new collaborations. Across three immersive tracks, dive into the conversations shaping the future of biopharma.
The headlines driving biotech and pharma innovation
The biggest stories in biotech and pharma are more than just headlines—they’re the foundation of the next wave of innovation. This year, we’re bringing the dealmakers behind these transformative stories to the stage in Vienna.
SpliceBio’s $135M Series B Strategy
SpliceBio is making waves with its advancements in gene therapy. Discover how this funding is driving innovation in precision medicine and genetic treatments.
ReproNovo’s $65M Series A Funding
ReproNovo’s latest funding round is revolutionizing reproductive health. Explore the strategies behind their success and what it means for the future of healthcare.
Scaling Success with WuXi AppTec:
WuXi AppTec is catalyzing Europe’s biotech transformation, driving growth and innovation across the region. Find out how their approach is setting new standards for success.
Funding the forgotten: Gates Foundation commits $2.5bn to women's health
The $2.5 billion funding from the Gates Foundation comes at a critical juncture. With the current US administration slashing budgets for women's health initiatives and reducing international aid for maternal health programs, the sector has been forced to rely even more on philanthropic funding.
Meet the Investors
Gain unfiltered insights into what’s driving success, overcoming challenges, and shaping the future of biopharma.
Agenda at a glance
Key event times, sessions, and networking opportunities, helping you plan your BIO-Europe experience.
